Carregant...
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer
BACKGROUND: Event-free survival (EFS) has been listed on the FDA Table of Surrogate Endpoints as a surrogate measure that can be considered for accelerated or traditional approval in breast cancer. However, no studies have evaluated the correlation between the treatment effects on EFS and treatment...
Guardat en:
| Publicat a: | EClinicalMedicine |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7910654/ https://ncbi.nlm.nih.gov/pubmed/33681740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2021.100730 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|